The pharmaceutical industry will continue to experience huge challenges and demanding changes in the upcoming years. Outsourcing in the pharmaceutical industry is not new for everything from research for new drug discovery to the manufacturing process, has been outsourced to emerging markets across the world.

In 2016, the following trends will further push the need to outsource the manufacturing process.

Increased cost pressure

The upcoming years will impose much cost pressure on the pharmaceutical companies due to the prevailing economic uncertainties and expiring patents. Thus more and more companies will be willing to outsource their manufacturing process and also look for reliable bulk suppliers for chemicals and intermediates like 3-Dimethylaminopropyl chloride hydrochloride 5407-04-5.

Optimization of machinery for enhanced OEE

As the pressure over cost builds up, it becomes mandatory to optimize the use of machinery and increase the Overall Equipment Effectiveness (OEE). This in turn allows maximum cost efficiency in manufacturing as well as in packaging. The need to add more flexibility, automation and agility to the manufacturing process is best left to the bulk manufacturer who offers fine chemicals like Bis (2-chloroethyl) amine hydrochloride 821-48-7. By doing so, pharmaceutical companies can focus better on their core research and development activities.

Increase of personalized medicine

The field of personalized medicine is certain to grow to a large extent in the next decade. This trend will aggravate the pace of the market and complex technologies and equipment will be deployed in the manufacturing process.

Thus outsourcing the manufacturing process can yield a whole set of benefits to the pharmaceutical companies in the following years.